BSE filing, NSE: BAFNAPH. Summary written from the filing by ALFA Finder's alert engine.
Bafna Pharmaceuticals Ltd: key numbers
- Share price
- ₹447.90
- Market cap
- ₹1,060 Cr
- Revenue (annual)
- ₹150.6 Cr
- Net profit (annual)
- ₹11.10 Cr
- P/E (TTM)
- 136.1×Sector 45.9×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 9.34%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bafna Pharmaceuticals Ltd
All →Bafna Pharmaceuticals Other Announcement
Bafna Pharmaceuticals Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI regulations.
Bafna Pharmaceuticals Annual General Meeting
Bafna Pharmaceuticals' 31st AGM held on September 11, 2026 approved adoption of audited financials, a director re-appointment, and cost auditor ratification. No specific monetary transaction was transacted.
Bafna Pharmaceuticals Annual Report
Bafna Pharmaceuticals Limited has submitted its Annual Report for the financial year 2025-2026 and announced the date for its 31st Annual General Meeting.
Bafna Pharmaceuticals Annual General Meeting
Bafna Pharmaceuticals Limited will hold its 31st Annual General Meeting on September 11, 2026. The book closure is scheduled from September 05 to September 11, 2026.
Bafna Pharmaceuticals Q1 FY27 Results: Net Profit ₹0.1 Cr, Down 97.1% YoY
Bafna Pharmaceuticals Ltd reported revenue from operations of ₹26.6 Cr (-23.1% YoY) and net profit of ₹0.1 Cr (-97.1% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.1 Cr · -97.1% YoY
Bafna Pharmaceuticals Board Meeting Date
Bafna Pharmaceuticals has scheduled a board meeting for August 11, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Other other announcement announcements
All →Trident Other Announcement
Trident disclosed an ESG rating of 65.88 from Niche Ninety Nine, based on public data. The company did not engage the agency.
Tata Chemicals Other Announcement
Tata Chemicals disclosed an ESG score of 68.74 from Niche Ninety Nine, an unengaged provider. The score uses public FY2025-26 data; no operational impact.
Usha Martin Other Announcement
Usha Martin disclosed a voluntary ESG rating of 69.57 assigned by Niche99, a SEBI-registered ESG Rating Provider, based on FY 2025-26 public data. The company did not engage the provider and the rating was not commissioned.
Robokidz Eduventures Other Announcement
Robokidz Eduventures filed its quarterly shareholding pattern for the period ended 30 September 2026. This is routine SEBI Regulation 31 disclosure with no transaction or corporate event.
Natco Pharma Other Announcement
Natco Pharma filed its shareholding pattern with a reporting date of 23 October 2026. Promoter and promoter group hold about 46% of total equity.
Innomet Advanced Materials Other Announcement
Innomet Advanced Materials filed its half-year Reg 32 statement on preferential issue proceeds, with no deviation. Rs.753.25 lakh raised in August 2026 was fully used for working capital.